Back
Akero Therapeutics Vs. Manhattan Associates Industry Stock Comparison
Sell
34
AKRO
Akero Therapeutics
Last Price:
19.94
Seasonality Move:
19.74%
Buy
57
MANH
Manhattan Associates
Last Price:
228.69
Seasonality Move:
6.31%
Sell
34
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.92. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Manhattan Associates (MANH)
is a Buy
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $228.78. The Score for MANH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MANH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $228.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MANH is experiencing slight buying pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 42.74 | Sell |
| Chaikin Money Flow: | -318844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.75 - 21.41) | Sell |
| Bollinger Bands (100): | (20.09 - 25.99) | Sell |
MANH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.22 | Sell |
| Relative Strength Index (14 RSI): | 58.04 | Buy |
| Chaikin Money Flow: | 154990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (209.61 - 227.23) | Buy |
| Bollinger Bands (100): | (215.08 - 250.32) | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.51 | Sell |
| 20-day SMA: | 20.4 | Sell |
| 50-day SMA: | 22.86 | Sell |
| 200-day SMA: | 27.08 | Sell |
| 8-day EMA: | 20.5 | Sell |
| 20-day EMA: | 20.8 | Sell |
| 50-day EMA: | 21.92 | Sell |
| 200-day EMA: | 26.48 | Sell |
MANH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 219.73 | Buy |
| 20-day SMA: | 215.69 | Buy |
| 50-day SMA: | 232.88 | Sell |
| 200-day SMA: | 218.63 | Buy |
| 8-day EMA: | 221.13 | Buy |
| 20-day EMA: | 220.49 | Buy |
| 50-day EMA: | 227.23 | Buy |
| 200-day EMA: | 217.07 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.06 per share, and a decrease next year of $0.47 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.51 per share.
Akero Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Manhattan Associates Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||